# Aspire Indiana Health Inc

Health Center, IN
Page: https://astrelis.co/providers/health_center/151001  
This twin: https://astrelis.co/providers/health_center/151001.md  
CMS Certification Number (CCN): 151001  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 12,827. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total visits (all service types) (FY2024):** 36,556. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 12. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 10.3%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -142.1%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $12.7M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** +10.5%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Aspire Indiana Health, Inc., IN

Match to this profile: matched by name (method: exact name and state (FACLAND tier 1)).

- FY ending 2025-06-30 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-06-GSAFAC-0000398085
- FY ending 2024-06-30 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-06-GSAFAC-0000061981
- FY ending 2023-06-30 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-06-GSAFAC-0000026399

| Line | FY ending 2025-06-30 | FY ending 2024-06-30 | FY ending 2023-06-30 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 31,339,983 [derived, p.6] | 42,350,250 [derived, p.6] | 46,875,870 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 2,887,579 [derived, p.6] | 1,644,080 [derived, p.6] | 1,200,169 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 4,469,759 [derived, p.6] | 5,975,627 [derived, p.6] | 4,074,684 [derived, p.6] |
| other current assets (Statement of financial position) | 808,841 [derived, p.6] | 436,538 [derived, p.6] | 313,734 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 39,506,162 [extracted, p.6] | 50,406,495 [extracted, p.6] | 52,464,457 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 28,909,151 [derived, p.6] | 27,369,428 [derived, p.6] | 26,623,127 [derived, p.6] |
| other long-term assets (Statement of financial position) | 4,748,391 [derived, p.6] | 2,254,655 [derived, p.6] | 1,982,745 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 73,163,704 [extracted, p.6] | 80,030,578 [extracted, p.6] | 81,070,329 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 6,248,140 [derived, p.6] | 5,162,368 [derived, p.6] | 3,879,426 [derived, p.6] |
| deferred revenue (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| current debt and leases (Statement of financial position) | 640,447 [derived, p.6] | 597,183 [derived, p.6] | 607,922 [derived, p.6] |
| other current liabilities (Statement of financial position) | 267,892 [derived, p.6] | 542,432 [derived, p.6] | 813,065 [derived, p.6] |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 7,156,479 [extracted, p.6] | 6,301,983 [extracted, p.6] | 5,300,413 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 12,356,152 [derived, p.6] | 10,830,802 [derived, p.6] | 11,424,629 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | 280,518 [derived, p.6] | 301,505 [derived, p.6] | 202,261 [derived, p.6] |
| TOTAL LIABILITIES (Statement of financial position) | 19,793,149 [extracted, p.6] | 17,434,290 [extracted, p.6] | 16,927,303 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 49,241,894 [derived, p.6] | 61,130,246 [derived, p.6] | 62,676,984 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | 4,128,661 [derived, p.6] | 1,466,042 [derived, p.6] | 1,466,042 [derived, p.6] |
| TOTAL NET ASSETS (Statement of financial position) | 53,370,555 [extracted, p.6] | 62,596,288 [extracted, p.6] | 64,143,026 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 31,476,175 [derived, p.7] | 26,256,977 [derived, p.7] | 24,771,040 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | 18,932,736 [derived, p.7] | 18,785,217 [derived, p.7] | 14,843,420 [derived, p.7] |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 22,853,181 [derived, p.7] | 22,831,043 [derived, p.7] | 22,278,541 [derived, p.7] |
| contributions (Statement of activities) | 237,228 [derived, p.7] | 541,023 [derived, p.7] | 204,747 [derived, p.7] |
| other revenue (Statement of activities) | 3,780,242 [derived, p.7] | 3,744,802 [derived, p.7] | 2,782,120 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 77,279,562 [extracted, p.7] | 72,159,062 [extracted, p.7] | 64,879,868 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 60,826,517 [derived, p.7] | 48,037,565 [derived, p.7] | 40,361,302 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | 12,270,453 [derived, p.7] | 12,598,104 [derived, p.7] | 8,781,520 [derived, p.7] |
| purchased and professional services (Statement of activities) | 5,085,544 [derived, p.7] | 4,267,136 [derived, p.7] | 3,615,704 [derived, p.7] |
| occupancy (Statement of activities) | 5,597,930 [derived, p.7] | 4,739,389 [derived, p.7] | 4,819,687 [derived, p.7] |
| depreciation and amortization (Statement of activities) | 2,300,137 [derived, p.7] | 2,167,773 [derived, p.7] | 1,979,120 [derived, p.7] |
| interest (Statement of activities) | 392,188 [derived, p.7] | 397,252 [derived, p.7] | 420,262 [derived, p.7] |
| other expenses (Statement of activities) | 4,569,406 [derived, p.7] | 4,079,029 [derived, p.7] | 3,272,707 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 91,042,175 [extracted, p.7] | 76,286,248 [extracted, p.7] | 63,250,302 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | -13,762,613 [extracted, p.7] | -4,127,186 [extracted, p.7] | 1,629,566 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | 4,536,880 [derived, p.7] | 2,580,448 [derived, p.7] | 2,005,296 [derived, p.7] |
| CHANGE IN NET ASSETS (Statement of activities) | -9,225,733 [extracted, p.7] | -1,546,738 [extracted, p.7] | 3,634,862 [extracted, p.7] |
| net assets, beginning (Statement of activities) | 62,596,288 [extracted, p.7] | 64,143,026 [extracted, p.7] | 60,508,164 [extracted, p.7] |
| net assets, end (Statement of activities) | 53,370,555 [extracted, p.7] | 62,596,288 [extracted, p.7] | 64,143,026 [extracted, p.7] |

| Ratio | FY ending 2025-06-30 | FY ending 2024-06-30 | FY ending 2023-06-30 |
|---|---:|---:|---:|
| Days cash on hand | 129 days [plausible] | 209 days [plausible] | 279 days [plausible] |
| Current ratio | 5.52x [plausible] | 8.00x [plausible] | 9.90x [plausible] |
| Operating margin | -17.8% [plausible] | -5.7% [plausible] | 2.5% [plausible] |
| Total margin | -11.9% [plausible] | -2.1% [plausible] | 5.6% [plausible] |
| Patient revenue share | 40.7% [plausible] | 36.4% [plausible] | 38.2% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | 66.8% [plausible] | 63.0% [plausible] | 63.8% [plausible] |
| Days in patient receivables | 33 days [plausible] | 23 days [plausible] | 18 days [plausible] |
| Debt to net assets | 0.24x [plausible] | 0.18x [plausible] | 0.19x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Aspire Indiana Health, Inc.; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Aspire Indiana Health Inc", https://astrelis.co/providers/health_center/151001, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.